Related Experiment Video
Updated: Dec 7, 2025

04:57
Prone Lateral Minimally Invasive Retropleural Corpectomy Using a Rotatable Radiolucent Jackson Table
Published on: July 3, 2025
714
Clinical Variation Reduction in Propensity-matched Patients Treated for Malignant Pleural Effusion
Richard K Freeman1, Kody Wyant2, Anthony J Ascioti1
1Division of Thoracic and Cardiovascular Surgery, St Vincent Hospital, Indianapolis, Indiana.
The Annals of Thoracic Surgery
|September 28, 2020
Summary
Standardizing care for malignant pleural effusion (MPE) through an evidence-based algorithm improves patient outcomes and reduces hospital costs. This approach optimizes treatment for MPE patients, leading to fewer admissions and interventions.
Area of Science:
- Thoracic Surgery
- Oncology
- Health Services Research
Background:
- Malignant pleural effusion (MPE) presents significant variation in patient outcomes and healthcare costs.
- Reducing clinical variation can enhance patient outcomes and lower costs by standardizing care.
- Optimizing and standardizing MPE treatment is crucial for improving patient care and resource allocation.
Purpose of the Study:
- To evaluate the impact of a standardized, evidence-based treatment algorithm for MPE.
- To assess the potential for improving patient outcomes and reducing costs associated with MPE management.
- To compare the effectiveness of a standardized algorithm versus individualized care for MPE.
Main Methods:
- A propensity-matched cohort study comparing patients treated with a standardized MPE algorithm to those receiving individualized care.
- Data collected over a two-year period from a single institution and six affiliated hospitals.
- Key matching factors included age, performance status, and tumor histology; outcomes assessed were interventions, admissions, morbidity, and costs.
Main Results:
- Patients treated with the standardized algorithm showed significantly fewer hospital admissions and readmissions.
- The algorithm group experienced a significant reduction in interventions and associated costs.
- Procedural morbidity was comparable between the algorithm-treated group and the individualized care group.
Conclusions:
- An evidence-based treatment algorithm for MPE significantly improves clinical outcomes compared to individualized therapy.
- Standardized care pathways for MPE lead to substantial reductions in healthcare costs.
- Implementing standardized algorithms is a viable strategy for optimizing MPE management.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
454
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
454
Pleural Effusion I: Introduction
3.2K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
3.2K
Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K

